)
Visual
earnings real time
Endo
Endo (NDOI) investor relations material
Endo has been delisted
Endo Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary6 Aug, 2025
Executive summary
Mallinckrodt and Endo Inc. completed their merger on July 31, 2025, forming a larger, more diversified pharmaceutical company.
Cristiana Stamolis was appointed as the new President and CFO, bringing biotech, finance, and strategy expertise.
Integration plans are underway, targeting $150 million in annual pre-tax run-rate operating synergies by year three.
Financial highlights
Legacy Endo's Q2 2025 revenues were $448 million, flat year-over-year; adjusted EBITDA was $150 million, down from $176 million.
Excluding the divested international segment, Endo's revenues grew 2% year-over-year.
Legacy Mallinckrodt's Q2 2025 net sales were $485 million, down 6% year-over-year; net income was $2 million, up from a $43 million loss.
Mallinckrodt's adjusted EBITDA was $137 million, down from $174 million year-over-year.
Outlook and guidance
2025 total company net sales expected between $3.57 billion and $3.62 billion; adjusted EBITDA between $1.1 billion and $1.13 billion.
Par Health net sales projected at $1.72–$1.75 billion, with adjusted EBITDA of $450–$470 million.
AXSAR Gel 2025 net sales guidance raised to 20%-30% growth; XIAFLEX revenue growth reaffirmed in the high single digits.
Planned spin-off of Par Health in Q4 2025, subject to board approval.
New CFO's role in synergy realization
Strategic rationale for Par Health spin-off
Mitigating competitive pressure on INOmax and injectables
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- SVEA
Net profit rose 41% to 10,910 MSEK in 2025, with a proposed 1,338 MSEK dividend. - SWK
Gross margin and net income rose, with CAM divestiture set to reduce debt and boost 2026 outlook. - TOM2
Record Automotive backlog and margin gains offset a 3% revenue decline in 2025. - CMBT
Q1 profit, Golden Ocean merger, and decarbonization drive strong outlook. - CBT
Adjusted EPS down 13% to $1.53 as Battery Materials growth offset Reinforcement Materials decline. - ADVENZYMES
Q3 FY26 revenue up 2% YoY, PAT up 11%, with wind power SPV investment approved. - SIMO
Q4 2025 revenue and margins surged on SSD, eMMC/UFS, and automotive growth; 2026 outlook strong. - FSV
Annual revenue up 5% to $5.50B; Adjusted EBITDA and EPS both saw double-digit growth. - QLINEA
Over 400% revenue growth in 2025, with US expansion and breakeven targeted for 2027. - OMV
Clean CCS Operating Result down 10% year-over-year, with strong cash flow and 9.3% dividend yield.
Endo
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Endo Inc. is a pharmaceutical company engaged in the development, manufacturing, and distribution of branded and generic medicines. The company focuses on a range of therapeutic areas, including pain management, urology, and dermatology. It provides prescription medications, specialty pharmaceuticals, and sterile injectables to healthcare providers and patients. The company is headquartered in Malvern, Pennsylvania, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage